Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. März 2019 07:30 ET | Quelle: Zenosense, Inc.

Zenosense, Inc.: Update on MIDS Medical Test Strip Development

VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
02. Oktober 2018 07:30 ET | Quelle: Zenosense, Inc.

Zenosense, Inc.: MIDS Medical Expands Technical Team

VALENCIA, SPAIN, Oct. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
05. September 2018 07:30 ET | Quelle: Zenosense, Inc.

Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million

VALENCIA, SPAIN, Sept. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
10. Juli 2018 08:00 ET | Quelle: Zenosense, Inc.

Zenosense Trading on the OTCQB Venture Market

VALENCIA, SPAIN, July 10, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the...
19. Juni 2018 07:30 ET | Quelle: Zenosense, Inc.

Zenosense, Inc.: Breakthrough Quantitative MIDS Testing Results

VALENCIA, SPAIN., June 19, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of...
24. Mai 2018 08:43 ET | Quelle: Zenosense, Inc.

Zenosense, Inc.: MIDS Shareholder Update

VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and...